News
Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...
From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...
It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...
In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...
The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...
Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...
The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...
Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...
"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...
New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results